跳至主要内容
临床试验/NCT05862389
NCT05862389招募中不适用

Study on the Mechanism of Eating Disorder

Peking University1 个研究点 分布在 1 个国家目标入组 750 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
750
试验地点
1
主要终点
The change of eating disorder behaviors and cognition

研究概览

简要总结

Eating disorders (EDs) are severe chronic psychiatric disorders with a not fully understood etiopathogenesis. Previous studies have revealed some biological mechanisms of EDs. However, the etiology and maintenance mechanism of EDs, especially the neuro-mechanisms is still unknown. To explore the pathogenic mechanism and treatment biomarkers of EDs, we design this study. the multidimensional data including the clinicopathological features, neuroimaging data (functional and structural magnetic resonance imaging), electroencephalogram and inflammatory cytokines will be used to investigate the biomarkers for diagnosis and treatment effectiveness.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
13 Years 至 35 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Anorexia nervosa
  • Anorexia nervosa according to Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5);
  • Age: 13-35 (including 13 and 35)
  • BMI: 13-17.5kg/m^2
  • The participants and/or their legal guardians ( for participants who are younger than 18-year-old) sign the informed consent form voluntarily and agree to participate in all visits and examinations as required by the trial protocol.
  • Do not take any psychiatric medications in past one month.
  • Bulimia nervosa
  • Bulimia nervosa according to Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5);
  • Age: 13-35 years old (including 13 and 35)
  • The participants and/or their legal guardians ( for participants who are younger than 18-year-old) sign the informed consent form voluntarily and agree to participate in all visits and examinations as required by the trial protocol.
  • Do not take any psychiatric medications in past one month.

排除标准

  • Patients who meet DSM-5 diagnostic criteria for other mental disorders: Major depressive disorder, anxiety, obsessive-compulsive disorder, personality disorder, mental retardation; drug and/or alcohol dependence;
  • Patients who receive repetitive Transcranial Magnetic Stimulation (rTMS) or modified electroconvulsive therapy (MECT) treatment in past six months.
  • Patients with severe suicidal tendencies or suicidal behavior
  • Pregnant or lactating women;
  • Patients with MRI contraindications;
  • Patients who are regarded as unsuitable by investigators for this clinical trial.

结局指标

主要结局

The change of eating disorder behaviors and cognition

时间窗: Day 0 to Day 56

The change of scores of Eating Disorder Examination Questionnaire (EDEQ) will be used to estimate the change of behaviors and cognition during treatment.The maximum score of EDEQ is 32.5 and the minium score is 0.

The change of severity of illness at 8 weeks

时间窗: Day 0 to Day 56

The change of scores of Eating disorder Inventory (EDI) will be used to estimate the change of severity of illness. The scores of 8-week will be compared with those of baseline. The maximum of EDI is 396 and the minimum score is 0.

次要结局

  • The change of eating disorder behaviors and cognition(Day 0 to Day 28; Day 0 to Month 3; Day 0 to Month 6; Day 0 to Month 12)
  • The change of severity of illness at early or later timepoints during treatment(Day 0 to Day 28; Day 0 to Month 3; Day 0 to Month 6; Day 0 to Month 12)

研究者

发起方
Peking University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验